Everolimus Zentiva

Everolimus Zentiva is an oral medication used for various therapeutic purposes. This prescription drug is manufactured by Zentiva, K.S. and is available in the EU market.

Everolimus Zentiva is primarily used for its immunosuppressive and antiproliferative properties. It is often prescribed to prevent organ rejection in transplant patients and to treat certain types of cancer. The medication works by inhibiting the activity of mTOR, a protein that regulates cell growth and proliferation. Patients should consult their healthcare provider to understand the specific uses of Everolimus Zentiva for their condition.

Common effects of Everolimus Zentiva may include fatigue, mouth sores, and swelling. Some users may also experience gastrointestinal issues such as nausea or diarrhea. These effects can vary in intensity and duration depending on the individual. It is important to monitor any side effects and discuss them with a healthcare professional.

Everolimus Zentiva should be handled with care and stored as directed. It is essential to follow the prescribed dosage and administration instructions provided by a healthcare provider. Patients should inform their doctor about any existing medical conditions or allergies before starting treatment. Regular monitoring may be required to ensure the medication's safety and effectiveness.

Everolimus Zentiva may interact with certain medications, including those that are metabolized by the liver's cytochrome P450 system. It is important to avoid grapefruit and grapefruit juice, as they can affect the metabolism of the drug. Patients should also be cautious with other immunosuppressive drugs and discuss all current medications with their healthcare provider.